<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(15)</volume><submitter>Ng L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The microRNA miR-187-3p plays antitumor roles in a variety of cancers. We and others have previously identified miR-187-3p as a potential tumor suppressor in colorectal cancer (CRC), but there are also reports revealing that high miR-187-3p levels are associated with poor prognosis among CRC patients. This study further investigated the clinicopathological significance of miR-187-3p in CRC.&lt;h4>Methods&lt;/h4>MiR-187-3p levels in paired polyp/CRC/normal specimens or primary CRC/liver metastasis specimens were determined by qPCR, and correlated with the patient's clinicopathological and postoperative survival data. The clinical findings were validated using our validation cohort and data obtained from the TCGA or GEO databases. The functional effects of miR-187-3p were invest</pubmed_abstract><journal>Cells</journal><pagination>2421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9367907</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer.</pubmed_title><pmcid>PMC9367907</pmcid><pubmed_authors>Lo OS</pubmed_authors><pubmed_authors>Ng L</pubmed_authors><pubmed_authors>Sin RW</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Man AT</pubmed_authors><pubmed_authors>Iyer DN</pubmed_authors><pubmed_authors>Wan TM</pubmed_authors><pubmed_authors>Foo DC</pubmed_authors><pubmed_authors>Law WL</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Levels of Tumor miR-187-3p-A Potential Tumor-Suppressor microRNA-Are Correlated with Poor Prognosis in Colorectal Cancer.</name><description>&lt;h4>Background&lt;/h4>The microRNA miR-187-3p plays antitumor roles in a variety of cancers. We and others have previously identified miR-187-3p as a potential tumor suppressor in colorectal cancer (CRC), but there are also reports revealing that high miR-187-3p levels are associated with poor prognosis among CRC patients. This study further investigated the clinicopathological significance of miR-187-3p in CRC.&lt;h4>Methods&lt;/h4>MiR-187-3p levels in paired polyp/CRC/normal specimens or primary CRC/liver metastasis specimens were determined by qPCR, and correlated with the patient's clinicopathological and postoperative survival data. The clinical findings were validated using our validation cohort and data obtained from the TCGA or GEO databases. The functional effects of miR-187-3p were invest</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T08:01:35.289Z</modification><creation>2025-04-04T08:01:35.289Z</creation></dates><accession>S-EPMC9367907</accession><cross_references><pubmed>35954265</pubmed><doi>10.3390/cells11152421</doi></cross_references></HashMap>